Form 8-K - Current report:
SEC Accession No. 0001104659-25-051289
Filing Date
2025-05-21
Accepted
2025-05-21 07:00:25
Documents
12
Period of Report
2025-05-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515724d1_8k.htm   iXBRL 8-K 38470
  Complete submission text file 0001104659-25-051289.txt   204907

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acur-20250515.xsd EX-101.SCH 3020
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20250515_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20250515_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2515724d1_8k_htm.xml XML 3580
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 25970870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)